Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jul;94(1):138–145. doi: 10.1172/JCI117299

Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin.

M Bermann 1, C A Jaffe 1, W Tsai 1, R DeMott-Friberg 1, A L Barkan 1
PMCID: PMC296291  PMID: 7913710

Abstract

To investigate the mechanisms of the negative feedback inhibition of growth hormone (GH) secretion by IGF-I, we studied parameters of GH pulsatility in six normal, fed men before and during a 48-h infusion of recombinant human IGF-I (rhIGF-I) (10-15 micrograms/kg per h). Plasma levels of IGF-I increased from the baseline value of 163.5 +/- 9.3 micrograms/liter (mean +/- SE) to a new steady state of 452.0 +/- 20.9 micrograms/liter during the infusion. Plasma GH concentrations were measured every 10 min for 24 h during both saline and rhIGF-I infusions using a sensitive chemiluminescent assay. Overall, GH concentrations were suppressed during the rhIGF-I infusion by 85 +/- 3%, mainly by attenuating spontaneous GH pulse amplitude (77 +/- 4% suppression). The apparent GH pulse frequency was attenuated from 7.8 +/- 0.9 to 4.7 +/- 0.6 pulses/24 h (P = 0.006). Administration of rhIGF suppressed GH responses to exogenous GH-releasing hormone by 82 +/- 3%, and thyroid-stimulating hormone responses to thyrotropin-releasing hormone were also suppressed by 44 +/- 9%. This constellation of hormonal effects is most compatible with the rhIGF-I-induced stimulation of hypothalamic somatostatin secretion.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe H., Molitch M. E., Van Wyk J. J., Underwood L. E. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology. 1983 Oct;113(4):1319–1324. doi: 10.1210/endo-113-4-1319. [DOI] [PubMed] [Google Scholar]
  2. Asplin C. M., Faria A. C., Carlsen E. C., Vaccaro V. A., Barr R. E., Iranmanesh A., Lee M. M., Veldhuis J. D., Evans W. S. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1989 Aug;69(2):239–245. doi: 10.1210/jcem-69-2-239. [DOI] [PubMed] [Google Scholar]
  3. Barkan A. L., Stred S. E., Reno K., Markovs M., Hopwood N. J., Kelch R. P., Beitins I. Z. Increased growth hormone pulse frequency in acromegaly. J Clin Endocrinol Metab. 1989 Dec;69(6):1225–1233. doi: 10.1210/jcem-69-6-1225. [DOI] [PubMed] [Google Scholar]
  4. Berelowitz M., Firestone S. L., Frohman L. A. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology. 1981 Sep;109(3):714–719. doi: 10.1210/endo-109-3-714. [DOI] [PubMed] [Google Scholar]
  5. Berelowitz M., Szabo M., Frohman L. A., Firestone S., Chu L., Hintz R. L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 1981 Jun 12;212(4500):1279–1281. doi: 10.1126/science.6262917. [DOI] [PubMed] [Google Scholar]
  6. Chihara K., Minamitani N., Kaji H., Arimura A., Fujita T. Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood. Endocrinology. 1981 Dec;109(6):2279–2281. doi: 10.1210/endo-109-6-2279. [DOI] [PubMed] [Google Scholar]
  7. Chomczynski P., Downs T. R., Frohman L. A. Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. Mol Endocrinol. 1988 Mar;2(3):236–241. doi: 10.1210/mend-2-3-236. [DOI] [PubMed] [Google Scholar]
  8. Clemmons D. R., Klibanski A., Underwood L. E., McArthur J. W., Ridgway E. C., Beitins I. Z., Van Wyk J. J. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab. 1981 Dec;53(6):1247–1250. doi: 10.1210/jcem-53-6-1247. [DOI] [PubMed] [Google Scholar]
  9. Daughaday W. H., Mariz I. K., Blethen S. L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 1980 Oct;51(4):781–788. doi: 10.1210/jcem-51-4-781. [DOI] [PubMed] [Google Scholar]
  10. Faria A. C., Bekenstein L. W., Booth R. A., Jr, Vaccaro V. A., Asplin C. M., Veldhuis J. D., Thorner M. O., Evans W. S. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) 1992 Jun;36(6):591–596. doi: 10.1111/j.1365-2265.1992.tb02270.x. [DOI] [PubMed] [Google Scholar]
  11. Frohman L. A., Downs T. R., Clarke I. J., Thomas G. B. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest. 1990 Jul;86(1):17–24. doi: 10.1172/JCI114681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gelato M. C., Pescovitz O. H., Cassorla F., Loriaux D. L., Merriam G. R. Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women. J Clin Endocrinol Metab. 1984 Aug;59(2):197–201. doi: 10.1210/jcem-59-2-197. [DOI] [PubMed] [Google Scholar]
  13. Hartman M. L., Clayton P. E., Johnson M. L., Celniker A., Perlman A. J., Alberti K. G., Thorner M. O. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 1993 Jun;91(6):2453–2462. doi: 10.1172/JCI116480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hartman M. L., Veldhuis J. D., Vance M. L., Faria A. C., Furlanetto R. W., Thorner M. O. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab. 1990 May;70(5):1375–1384. doi: 10.1210/jcem-70-5-1375. [DOI] [PubMed] [Google Scholar]
  15. Ho K. Y., Evans W. S., Blizzard R. M., Veldhuis J. D., Merriam G. R., Samojlik E., Furlanetto R., Rogol A. D., Kaiser D. L., Thorner M. O. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987 Jan;64(1):51–58. doi: 10.1210/jcem-64-1-51. [DOI] [PubMed] [Google Scholar]
  16. Ho K. Y., Veldhuis J. D., Johnson M. L., Furlanetto R., Evans W. S., Alberti K. G., Thorner M. O. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 1988 Apr;81(4):968–975. doi: 10.1172/JCI113450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ho P. J., Friberg R. D., Barkan A. L. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly. J Clin Endocrinol Metab. 1992 Sep;75(3):812–819. doi: 10.1210/jcem.75.3.1517371. [DOI] [PubMed] [Google Scholar]
  18. Jaffe C. A., Friberg R. D., Barkan A. L. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest. 1993 Aug;92(2):695–701. doi: 10.1172/JCI116639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lucke C., Höffken B., von zur Mühlen A. The effect of somatostatin on TSH levels in patients with primary hypothyroidism. J Clin Endocrinol Metab. 1975 Dec;41(06):1082–1084. doi: 10.1210/jcem-41-6-1082. [DOI] [PubMed] [Google Scholar]
  20. Martha P. M., Jr, Rogol A. D., Veldhuis J. D., Kerrigan J. R., Goodman D. W., Blizzard R. M. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab. 1989 Sep;69(3):563–570. doi: 10.1210/jcem-69-3-563. [DOI] [PubMed] [Google Scholar]
  21. Morita S., Yamashita S., Melmed S. Insulin-like growth factor I action on rat anterior pituitary cells: effects of intracellular messengers on growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 1987 Dec;121(6):2000–2006. doi: 10.1210/endo-121-6-2000. [DOI] [PubMed] [Google Scholar]
  22. Plotsky P. M., Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science. 1985 Oct 25;230(4724):461–463. doi: 10.1126/science.2864742. [DOI] [PubMed] [Google Scholar]
  23. Robbins R. J., Leidy J. W., Jr, Landon R. M. The effects of growth hormone, prolactin, corticotropin, and thyrotropin on the production and secretion of somatostatin by hypothalamic cells in vitro. Endocrinology. 1985 Aug;117(2):538–543. doi: 10.1210/endo-117-2-538. [DOI] [PubMed] [Google Scholar]
  24. Sato M., Frohman L. A. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology. 1993 Aug;133(2):793–799. doi: 10.1210/endo.133.2.8102097. [DOI] [PubMed] [Google Scholar]
  25. Shibasaki T., Yamauchi N., Hotta M., Masuda A., Imaki T., Demura H., Ling N., Shizume K. In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. Regul Pept. 1986 Aug;15(1):47–53. doi: 10.1016/0167-0115(86)90074-1. [DOI] [PubMed] [Google Scholar]
  26. Snyder P. J., Utiger R. D. Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab. 1972 Feb;34(2):380–385. doi: 10.1210/jcem-34-2-380. [DOI] [PubMed] [Google Scholar]
  27. Straus D. S., Takemoto C. D. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol. 1990 Jan;4(1):91–100. doi: 10.1210/mend-4-1-91. [DOI] [PubMed] [Google Scholar]
  28. Tannenbaum G. S., Guyda H. J., Posner B. I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science. 1983 Apr 1;220(4592):77–79. doi: 10.1126/science.6338593. [DOI] [PubMed] [Google Scholar]
  29. Thomas G. B., Cummins J. T., Francis H., Sudbury A. W., McCloud P. I., Clarke I. J. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology. 1991 Feb;128(2):1151–1158. doi: 10.1210/endo-128-2-1151. [DOI] [PubMed] [Google Scholar]
  30. Vaccarello M. A., Diamond F. B., Jr, Guevara-Aguirre J., Rosenbloom A. L., Fielder P. J., Gargosky S., Cohen P., Wilson K., Rosenfeld R. G. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 1993 Jul;77(1):273–280. doi: 10.1210/jcem.77.1.7686916. [DOI] [PubMed] [Google Scholar]
  31. Vale W., Rivier C., Brazeau P., Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology. 1974 Oct;95(4):968–977. doi: 10.1210/endo-95-4-968. [DOI] [PubMed] [Google Scholar]
  32. Van Cauter E., Caufriez A., Kerkhofs M., Van Onderbergen A., Thorner M. O., Copinschi G. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J Clin Endocrinol Metab. 1992 Jun;74(6):1451–1459. doi: 10.1210/jcem.74.6.1592893. [DOI] [PubMed] [Google Scholar]
  33. Vance M. L., Borges J. L., Kaiser D. L., Evans W. S., Furlanetto R., Thominet J. L., Frohman L. A., Rogol A. D., MacLeod R. M., Bloom S. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. J Clin Endocrinol Metab. 1984 May;58(5):838–844. doi: 10.1210/jcem-58-5-838. [DOI] [PubMed] [Google Scholar]
  34. Veldhuis J. D., Johnson M. L. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 1986 Apr;250(4 Pt 1):E486–E493. doi: 10.1152/ajpendo.1986.250.4.E486. [DOI] [PubMed] [Google Scholar]
  35. Weeke J., Hansen A. P., Lundaek K. Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men. J Clin Endocrinol Metab. 1975 Jul;41(1):168–171. doi: 10.1210/jcem-41-1-168. [DOI] [PubMed] [Google Scholar]
  36. Williams T. C., Kelijman M., Crelin W. C., Downs T. R., Frohman L. A. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man. J Clin Endocrinol Metab. 1988 Jan;66(1):39–45. doi: 10.1210/jcem-66-1-39. [DOI] [PubMed] [Google Scholar]
  37. Williams T., Berelowitz M., Joffe S. N., Thorner M. O., Rivier J., Vale W., Frohman L. A. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984 Nov 29;311(22):1403–1407. doi: 10.1056/NEJM198411293112203. [DOI] [PubMed] [Google Scholar]
  38. Yamashita S., Weiss M., Melmed S. Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells. J Clin Endocrinol Metab. 1986 Sep;63(3):730–735. doi: 10.1210/jcem-63-3-730. [DOI] [PubMed] [Google Scholar]
  39. Zadik Z., Chalew S. A., Kowarski A. The definition of a spontaneous growth hormone (GH) peak: studies in normally growing and GH-deficient children. J Clin Endocrinol Metab. 1992 Apr;74(4):801–805. doi: 10.1210/jcem.74.4.1548344. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES